RAR-independent RXR signaling induces t(15;17) leukemia cell maturation

被引:102
作者
Benoit, G
Altucci, L
Flexor, M
Ruchaud, S
Lillehaug, J
Raffelsberger, W
Gronemeyer, H
Lanotte, M
机构
[1] Hop St Louis, Ctr G Hayem, INSERM, U496, F-75010 Paris, France
[2] ULP, CNRS, INSERM, IGBMC, F-67404 Illkirch, CU Strasbourg, France
关键词
differentiation; leukemia; nuclear receptors; protein kinase A; retinoids; signal transduction;
D O I
10.1093/emboj/18.24.7011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although retinoic acid receptor alpha (RAR alpha) agonists induce the maturation of t(15;17) acute promyelocytic leukemia (APL) cells, drug treatment also selects leukemic blasts expressing PML-RAR alpha fusion proteins with mutated ligand-binding domains that no longer respond to all-trans retinoic acid (ATRA). Here we report a novel RAR alpha-independent signaling pathway that induces maturation of both ATRA-sensitive and ATRA-resistant APL NB4 cells, and does not invoke the ligand-induced alteration of PML-RARa signaling, stability or compartmentalization. This response involves a cross-talk between RXR agonists and protein kinase A signaling. Our results indicate the existence of a separate RXR-dependent maturation pathway that can be activated in the absence of known ligands for RXR heterodimerization partners.
引用
收藏
页码:7011 / 7018
页数:8
相关论文
共 55 条
[31]   REGULATION OF RETINOID SIGNALING BY RECEPTOR POLARITY AND ALLOSTERIC CONTROL OF LIGAND-BINDING [J].
KUROKAWA, R ;
DIRENZO, J ;
BOEHM, M ;
SUGARMAN, J ;
GLOSS, B ;
ROSENFELD, MG ;
HEYMAN, RA ;
GLASS, CK .
NATURE, 1994, 371 (6497) :528-531
[32]   Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors α1 and γ [J].
Labrecque, J ;
Allan, D ;
Chambon, P ;
Iscove, NN ;
Lohnes, D ;
Hoang, T .
BLOOD, 1998, 92 (02) :607-615
[33]   Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia [J].
Lallemand-Breitenbach, V ;
Guillemin, MC ;
Janin, A ;
Daniel, MT ;
Degos, L ;
Kogan, SC ;
Bishop, JM ;
de Thé, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1043-1052
[34]  
LANOTTE M, 1991, BLOOD, V77, P1080
[35]   RETINOIDS SELECTIVE FOR RETINOID-X RECEPTOR RESPONSE PATHWAYS [J].
LEHMANN, JM ;
JONG, L ;
FANJUL, A ;
CAMERON, JF ;
LU, XP ;
HAEFNER, P ;
DAWSON, MI ;
PFAHL, M .
SCIENCE, 1992, 258 (5090) :1944-1946
[36]   Role of the histone deacetylase complex in acute promyelocytic leukaemia [J].
Lin, RJ ;
Nagy, L ;
Inoue, S ;
Shao, WL ;
Miller, WH ;
Evans, RM .
NATURE, 1998, 391 (6669) :811-814
[37]  
MADER S, 1993, J BIOL CHEM, V268, P591
[38]   THE NUCLEAR RECEPTOR SUPERFAMILY - THE 2ND DECADE [J].
MANGELSDORF, DJ ;
THUMMEL, C ;
BEATO, M ;
HERRLICH, P ;
SCHUTZ, G ;
UMESONO, K ;
BLUMBERG, B ;
KASTNER, P ;
MARK, M ;
CHAMBON, P ;
EVANS, RM .
CELL, 1995, 83 (06) :835-839
[39]   Initial clinical trial of a selective retinoid X receptor ligand, LGD1069 [J].
Miller, VA ;
Benedetti, FM ;
Rigas, JR ;
Verret, AL ;
Pfister, DG ;
Straus, D ;
Kris, MG ;
Crisp, M ;
Heyman, R ;
Loewen, GR ;
Truglia, JA ;
Warrell, RP .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :790-795
[40]   The nuclear receptor ligand-binding domain: structure and function [J].
Moras, D ;
Gronemeyer, H .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (03) :384-391